NCT03566914View on ClinicalTrials.gov

Tadalafil for Erectile Dysfunction in Patients With Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

December 28, 2019

Study Completion Date

December 28, 2019

Conditions
Cirrhosis
Interventions
DRUG

Tadalafil 10 MG

Tadalafil 10 mg per oral once daily for 3 months

OTHER

Placebo

TPlacebo tablet per oral once daily for 3 months

Trial Locations (1)

110070

Dr Rakesh Kumar Jagdish, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT03566914 - Tadalafil for Erectile Dysfunction in Patients With Cirrhosis | Biotech Hunter | Biotech Hunter